AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32747497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 33203707 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted plasma vitamin C
Number of subjects: 80
Study 33203707 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemically measured plasma vitamin C
Number of subjects: 80
Study 32629949 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel4Diabetes intervention group
Number of subjects: 2110
Study 32629949 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel4Diabetes intervention group (Greece and Spain)
Number of subjects: 2110
Study 32629949 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel4Diabetes intervention group (Belgium and Finland)
Number of subjects: 2110
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults with chronic conditions
Number of subjects: 2399
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults with multimorbidities
Number of subjects: 2399
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults who are care dependent
Number of subjects: 2399
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults' HRQoL and well-being
Number of subjects: 2399
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in health outcomes
Number of subjects: 2399
Study 36142050 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status (SES) impact
Number of subjects: 2399
Study 33798307 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Tiaoshen acupoints (Baihui, Shenting, Yintang, Shenmen, Sanyinjiao), treated once every other day, 3 times a week for 4 weeks.
Number of subjects: 60
Study 33798307 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (non-effective point shallow acupuncture), treated once every other day, 3 times a week for 4 weeks.
Number of subjects: 60
Study 33798307 — intervention group
Group type: COMPARATOR
Intervention: Comparison between acupuncture and sham acupuncture groups after treatment.
Number of subjects: 60
Study 35659393 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaboration with artificial intelligence (AI)
Number of subjects: 0
Study 35659393 — intervention group
Group type: COMPARATOR
Intervention: Standard clinician performance without AI
Number of subjects: 0
Study 32677851 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing-focused yoga for 8 weeks
Number of subjects: 72
Study 32677851 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation for 8 weeks
Number of subjects: 72
Study 33992032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementation through closure (CTC)
Number of subjects: 150
Study 33992032 — intervention group
Group type: EXPERIMENTAL
Intervention: No tourniquet (NT)
Number of subjects: 150
Study 33992032 — intervention group
Group type: COMPARATOR
Intervention: Full course (FC)
Number of subjects: 150
Study 33883079 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fecal microbiota transplantation (aFMT)
Number of subjects: 90
Study 33883079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34297268 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib 400 mg twice daily for 10 days
Number of subjects: 20
Study 34297268 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 20
Study 34815242 — intervention group
Group type: EXPERIMENTAL
Intervention: UHC Mode
Number of subjects: 196
Study 34815242 — intervention group
Group type: COMPARATOR
Intervention: Standard mobile application (control)
Number of subjects: 196
Study 35553356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Strength Training (IMST) at 15% of PImax
Number of subjects: 7
Study 35553356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Strength Training (IMST) at 75% of PImax
Number of subjects: 7
Study 35553356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Strength Training (IMST)
Number of subjects: 7
Study 33320286 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy with simultaneous integrated boost (SIB)
Number of subjects: 0
Study 33320286 — intervention group
Group type: COMPARATOR
Intervention: Hypofractionated RT with sequential boost (HFseq)
Number of subjects: 0
Study 33320286 — intervention group
Group type: COMPARATOR
Intervention: Normofractionated RT with sequential boost (NFseq)
Number of subjects: 0
Study 33320286 — intervention group
Group type: COMPARATOR
Intervention: Normofractionated RT with SIB (NFSIB)
Number of subjects: 0
Study 33957242 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 226
Study 33957242 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 226
Study 32946700 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 7593
Study 32946700 — intervention group
Group type: COMPARATOR
Intervention: Faecal immunochemical test (FIT)
Number of subjects: 7593
Study 34039952 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin (belamaf)
Number of subjects: 0
Study 35190414 — intervention group
Group type: EXPERIMENTAL
Intervention: SFP10‐14 intervention comprising seven weekly sessions
Number of subjects: 715
Study 35190414 — intervention group
Group type: COMPARATOR
Intervention: Existing services as normal (Control)
Number of subjects: 715
Study 35190414 — intervention group
Group type: EXPERIMENTAL
Intervention: SFP10‐14 intervention
Number of subjects: 715
Study 33470963 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-voice guided resuscitation
Number of subjects: 20
Study 33470963 — intervention group
Group type: COMPARATOR
Intervention: Non-guided resuscitation
Number of subjects: 20
Study 32282981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-frequency bio-impedance analysis (DF-BIA)
Number of subjects: 31
Study 32282981 — intervention group
Group type: COMPARATOR
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 31
Study 33634740 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial consequence frame
Number of subjects: 348
Study 33634740 — intervention group
Group type: EXPERIMENTAL
Intervention: Social consequence frame
Number of subjects: 348
Study 33634740 — intervention group
Group type: COMPARATOR
Intervention: Health consequence frame
Number of subjects: 348
Study 32057567 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet HP (high protein/low carbohydrate)
Number of subjects: 270
Study 32057567 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet S (standard severe hypocaloric diet)
Number of subjects: 270
Study 36092854 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Epidural Teaching Model (SETM)
Number of subjects: 44
Study 36092854 — intervention group
Group type: COMPARATOR
Intervention: Standard Teaching Module (SDM)
Number of subjects: 44
Study 616708360 — intervention group
Group type: EXPERIMENTAL
Intervention: Khanda Pippali Avaleha (10 g orally for 60 days)
Number of subjects: 30
Study 616708360 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg once a day for 60 days, empty stomach)
Number of subjects: 30
Study 34465402 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct maxillary sinus saline irrigation with systemic antibiotics and topical sprays (n = 24)
Number of subjects: 39
Study 34465402 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological therapy alone (n = 15)
Number of subjects: 39
Study 34465402 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n = 39)
Number of subjects: 39
Study 32090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola capsule (0.6 g/day) combined with sertraline
Number of subjects: 100
Study 32090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola capsule (0.3 g/day) combined with sertraline
Number of subjects: 100
Study 32090788 — intervention group
Group type: COMPARATOR
Intervention: Sertraline with two placebos (0.6 g/day)
Number of subjects: 100
Study 35299131 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers with various potential stressors and resource availability
Number of subjects: 1143
Study 35299131 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers in employment, placements provided by a non-government organisation, and caring for >1 child in OOHC
Number of subjects: 1143
Study 35299131 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers satisfied with caseworker assistance
Number of subjects: 1143
Study 35299131 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers across four trajectory groups
Number of subjects: 1143
Study 34358822 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low energy diet (VLED) of 1000 kcal/day for 8 weeks
Number of subjects: 64
Study 34569878 — intervention group
Group type: EXPERIMENTAL
Intervention: MT alone (direct MT) with stent retrievers
Number of subjects: 404
Study 34569878 — intervention group
Group type: COMPARATOR
Intervention: IVT + MT with stent retrievers
Number of subjects: 404
Study 34373383 — intervention group
Group type: EXPERIMENTAL
Intervention: OSATS educational module for Pavlik harness application (group 1)
Number of subjects: 40
Study 34373383 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 40
Study 32727393 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective feedback loop and tailored clinical response intervention
Number of subjects: 21
Study 32727393 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 21
Study 35952766 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based strength training program
Number of subjects: 123
Study 35952766 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 123
Study 33711288 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening at 12 months
Number of subjects: 5784
Study 33711288 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial screening
Number of subjects: 5784
Study 33711288 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat screening
Number of subjects: 5784
Study 33711288 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening at 18 months
Number of subjects: 5784
Study 33542153 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (active arm)
Number of subjects: 197
Study 33542153 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control arm)
Number of subjects: 197
Study 32383352 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (4 weeks, stationary bicycle training, 5 times per week for 30 minutes)
Number of subjects: 20
Study 32383352 — intervention group
Group type: COMPARATOR
Intervention: Balance training (4 weeks, home training with easy, moderate, and/or hard exercises for the same duration)
Number of subjects: 20
Study 32809966 — intervention group
Group type: COMPARATOR
Intervention: Normal saline vaginal wash (0.9% NaCl)
Number of subjects: 218
Study 32809966 — intervention group
Group type: COMPARATOR
Intervention: Alkaline vaginal wash (5% sodium bicarbonate)
Number of subjects: 218
Study 32809966 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidic vaginal wash (5% acetic acid)
Number of subjects: 218
Study 35303841 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 22
Study 35303841 — intervention group
Group type: COMPARATOR
Intervention: Sham-electroacupuncture
Number of subjects: 22
Study 35303841 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22
Study 33653757 — intervention group
Group type: COMPARATOR
Intervention: Oral high-dose vitamin D supplementation (50,000 IU cholecalciferol) taken monthly for 2 years, with an initial loading dose of 500,000 IU cholecalciferol.
Number of subjects: 0
Study 33653757 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 32353142 — intervention group
Group type: EXPERIMENTAL
Intervention: Septum resection
Number of subjects: 257
Study 32353142 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 257
Study 35025149 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (specific details on dosage and duration are not available)
Number of subjects: 0
Study 34959924 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation (4 × 500 mg capsules/day; total 2 g per day) combined with moderate-intensity training (1 h session/3 times a week)
Number of subjects: 45
Study 34959924 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 45
Study 34959924 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation
Number of subjects: 45
Study 34959924 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation and physical training
Number of subjects: 45
Study 33715956 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorus-restricted diet (n = 36)
Number of subjects: 71
Study 33715956 — intervention group
Group type: COMPARATOR
Intervention: Control diet (n = 35)
Number of subjects: 71
Study 34608032 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation
Number of subjects: 48
Study 34608032 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 48
Study 35065045 — intervention group
Group type: EXPERIMENTAL
Intervention: FASTER-assisted ESD
Number of subjects: 6
Study 35065045 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD
Number of subjects: 6
Study 33818370 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Anxiety from Cancer (MAC), a seven-session CBT-based psychotherapy intervention delivered over the telephone
Number of subjects: 29
Study 33818370 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 29
Study 35793882 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion combined with plucking technique at Jiquan (HT 1)
Number of subjects: 80
Study 35793882 — intervention group
Group type: COMPARATOR
Intervention: Routine care for PICC (Control)
Number of subjects: 80
Study 32196623 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg aspirin
Number of subjects: 446
Study 32196623 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin
Number of subjects: 446
Study 32196623 — intervention group
Group type: COMPARATOR
Intervention: Control (normouricaemic subjects)
Number of subjects: 446
Study 32196623 — intervention group
Group type: COMPARATOR
Intervention: Control (hyperuricaemic subjects)
Number of subjects: 446
Study 35731056 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone cement-enhanced APFN internal fixation
Number of subjects: 42
Study 35731056 — intervention group
Group type: COMPARATOR
Intervention: Conventional PFNA internal fixation
Number of subjects: 42
Study 33756239 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute physical fatigue induced by a 30 s modified Wingate
Number of subjects: 20
Study 36414575 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutritional supplement (LNS)
Number of subjects: 38
Study 36414575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage)
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage)
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for middle gastric cancer
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for middle gastric cancer
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for lower gastric cancer
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for lower gastric cancer
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for tumor in lesser curvature
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for tumor in lesser curvature
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for tumor in non-lesser curvature
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for tumor in non-lesser curvature
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage)
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage)
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN0
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN0
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN1
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN1
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN2
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN2
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN3
Number of subjects: 86
Study 32727193 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN3
Number of subjects: 86
Study 35283411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual group (aspirin plus cilostazol)
Number of subjects: 1188
Study 32860470 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed randomised two-arm binary outcome trial design with stochastic curtailment
Number of subjects: 0
Study 32860470 — intervention group
Group type: COMPARATOR
Intervention: Existing designs with early stopping
Number of subjects: 0
Study 32396535 — intervention group
Group type: EXPERIMENTAL
Intervention: Proficiency Based Progression (PBP) simulation training
Number of subjects: 0
Study 32396535 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 0
Study 32396535 — intervention group
Group type: EXPERIMENTAL
Intervention: PBP simulation training implemented across all workers
Number of subjects: 0
Study 35221282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low O2 (2%) tension
Number of subjects: 152
Study 35221282 — intervention group
Group type: COMPARATOR
Intervention: Control (5% O2 tension)
Number of subjects: 152
Study 32229520 — intervention group
Group type: EXPERIMENTAL
Intervention: PARTNER 2 intervention
Number of subjects: 690
Study 32229520 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 690
Study 34275830 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol dosing based on total body weight (TBW)
Number of subjects: 22
Study 34275830 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol dosing based on lean body weight (LBW)
Number of subjects: 22
Study 32044943 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (vancomycin or daptomycin + antistaphylococcal β-lactam)
Number of subjects: 352
Study 32044943 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (vancomycin or daptomycin alone)
Number of subjects: 352
Study 32044943 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 352
Study 32044943 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 352
Study 32044943 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (excluding dialysis patients)
Number of subjects: 352
Study 32044943 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (excluding dialysis patients)
Number of subjects: 352
Study 35392818 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver support training (manual based, 6 group sessions over 2 months)
Number of subjects: 170
Study 35392818 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 170
Study 34602433 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 33
Study 34602433 — intervention group
Group type: COMPARATOR
Intervention: Control (no propolis)
Number of subjects: 33
Study 33196606 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (60-min treadmill run at 65% ± 7% peak oxygen uptake)
Number of subjects: 24
Study 33196606 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 24
Study 33196606 — intervention group
Group type: COMPARATOR
Intervention: Control (resting for 9 h without exercise)
Number of subjects: 24
Study 32505019 — intervention group
Group type: EXPERIMENTAL
Intervention: Stifneck® collar
Number of subjects: 60
Study 32505019 — intervention group
Group type: COMPARATOR
Intervention: Philadelphia® collar
Number of subjects: 60
Study 32505019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both collars
Number of subjects: 60
Study 33822852 — intervention group
Group type: EXPERIMENTAL
Intervention: Care staff proxies
Number of subjects: 0
Study 33822852 — intervention group
Group type: COMPARATOR
Intervention: Residents
Number of subjects: 0
Study 32815921 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily for 12 weeks
Number of subjects: 30
Study 34915723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 0
Study 34915723 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 33173072 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT machines (7 different types)
Number of subjects: 7
Study 33173072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operator reproducibility
Number of subjects: 7
Study 33173072 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-operator reproducibility
Number of subjects: 7
Study 33173072 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective image quality measures and exposure parameters
Number of subjects: 7
Study 35267911 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-restricted (DEH) during walking/running at 55% V.O2max, 40 °C
Number of subjects: 10